214 related articles for article (PubMed ID: 36980204)
1.
Xu R; Wang X; Safi S; Braunegger N; Hipgrave Ederveen A; Rottmann M; Wittbrodt J; Wuhrer M; Wesslowski J; Davidson G
Cells; 2023 Mar; 12(6):. PubMed ID: 36980204
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.
Chen Q; Su Y; Wesslowski J; Hagemann AI; Ramialison M; Wittbrodt J; Scholpp S; Davidson G
EMBO Rep; 2014 Dec; 15(12):1254-67. PubMed ID: 25391905
[TBL] [Abstract][Full Text] [Related]
3. LRPs in WNT Signalling.
Davidson G
Handb Exp Pharmacol; 2021; 269():45-73. PubMed ID: 34490514
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity.
Beagle B; Mi K; Johnson GV
J Cell Biochem; 2009 Nov; 108(4):886-95. PubMed ID: 19711366
[TBL] [Abstract][Full Text] [Related]
7. In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling.
Hong S; Feng L; Yang Y; Jiang H; Hou X; Guo P; Marlow FL; Stanley P; Wu P
Cell Chem Biol; 2020 Sep; 27(9):1140-1150.e4. PubMed ID: 32649905
[TBL] [Abstract][Full Text] [Related]
8. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
10. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin.
Jiang Y; He X; Howe PH
EMBO J; 2012 May; 31(10):2336-49. PubMed ID: 22491013
[TBL] [Abstract][Full Text] [Related]
11. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.
Reinke L; Lam AP; Flozak AS; Varga J; Gottardi CJ
Biochem Biophys Res Commun; 2016 Feb; 470(3):606-612. PubMed ID: 26797284
[TBL] [Abstract][Full Text] [Related]
13. Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling.
Janda CY; Dang LT; You C; Chang J; de Lau W; Zhong ZA; Yan KS; Marecic O; Siepe D; Li X; Moody JD; Williams BO; Clevers H; Piehler J; Baker D; Kuo CJ; Garcia KC
Nature; 2017 May; 545(7653):234-237. PubMed ID: 28467818
[TBL] [Abstract][Full Text] [Related]
14. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
Lettini G; Condelli V; Pietrafesa M; Crispo F; Zoppoli P; Maddalena F; Laurenzana I; Sgambato A; Esposito F; Landriscina M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065966
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
16. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
[TBL] [Abstract][Full Text] [Related]
18. LRP6 regulates Rab7-mediated autophagy through the Wnt/β-catenin pathway to modulate trophoblast cell migration and invasion.
Li L; Peng W; Zhou Q; Wan JP; Wang XT; Qi HB
J Cell Biochem; 2020 Feb; 121(2):1599-1609. PubMed ID: 31544984
[TBL] [Abstract][Full Text] [Related]
19. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
[TBL] [Abstract][Full Text] [Related]
20. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
